MS RESEARCH AUSTRALIA TRIALS
Australian researchers are one step closer to clinical trials for a treatment option that could potentially repair damage to the brain caused by MS.
Three MS treatments will be considered for inclusion on the PBS at a PBAC meeting in March – nabiximols (Sativex), siponimod (Mayzent), ozanimod (Zeposia).
MS Research Australia has funded six new MS studies totalling almost $150,000 in the first round of incubator […]
Associate Professor Kaylene Young and Professor Bruce Taylor are working towards new discoveries that may provide treatments to […]
The first ever treatment for secondary progressive MS, a form of MS that can follow on from relapsing remitting MS, has been approved in Australia.